Stock AAQ AAP IMPLANTATE AG
Add to a list
To use this feature you must be a member
Log inSign up

Ratings aap Implantate AG Xetra

Equities

AAQ

DE0005066609

End-of-day quote Xetra
Other stock markets
 18:00:00 2024-02-04 EST 		5-day change 1st Jan Change
0.73 EUR -2.67% Intraday chart for aap Implantate AG -9.32% -12.05%
2021 Aap Implantate AG Announces Sales Results for the Second Quarter and Half Year Ended 30 June 2021 CI
2021 Aap Implantate Ag Reports Earnings Results for the Full Year Ended December 31, 2020 CI

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

  • The company appears to be poorly valued given its net asset value.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Low profitability weakens the company.
  • The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
AAP IMPLANTATE AG Stock aap Implantate AG
-12.05% 12.23M -
ABBOTT LABORATORIES Stock Abbott Laboratories
-3.41% 184B
C+
MEDTRONIC PLC Stock Medtronic plc
-2.21% 107B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.47% 67.78B
A
DEXCOM, INC. Stock DexCom, Inc.
+0.58% 50.66B
B-
CENCORA, INC. Stock Cencora, Inc.
+12.16% 47.64B
B-
HOYA CORPORATION Stock Hoya Corporation
+4.60% 41.12B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+1.11% 26.3B
B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+1.72% 26.04B
A-
TERUMO CORPORATION Stock Terumo Corporation
+15.06% 25.4B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. AAQ1 Stock
  4. AAQ Stock
  5. Ratings aap Implantate AG